We are live on
!
Find out more
Kymera Therapeutics
KYMR
KYMR
128 hedge funds and large institutions have $2.76B invested in Kymera Therapeutics in 2021 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 54 increasing their positions, 28 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
2,902% more call options, than puts
Call options by funds: $8.82M | Put options by funds: $294K
115% more first-time investments, than exits
New positions opened: 28 | Existing positions closed: 13
93% more repeat investments, than reductions
Existing positions increased: 54 | Existing positions reduced: 28
50% more funds holding in top 10
Funds holding in top 10: 4 → 6 (+2)
36% more capital invested
Capital invested by funds: $2.04B → $2.76B (+$723M)
16.74% more ownership
Funds ownership: 67.86% → 84.6% (+17%)
11% more funds holding
Funds holding: 115 → 128 (+13)
Holders
128
Holders Change
+13
Holders Change %
+11.3%
% of All Funds
1.97%
Holding in Top 10
6
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+50%
% of All Funds
0.09%
New
28
Increased
54
Reduced
28
Closed
13
Calls
$8.82M
Puts
$294K
Net Calls
+$8.53M
Net Calls Change
-$4.01M
Top Buyers
| 1 |
AG
Artal Group
Luxembourg
|
+$34.9M |
| 2 |
BlackRock
New York
|
+$20.8M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$18.5M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$13.2M |
| 5 |
State Street
Boston,
Massachusetts
|
+$11.8M |
